Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Anti-CD33 antibodies and methods for treatment of acute myeloid leukemia using the same

Anti-CD33 antibodies and methods for treatment of acute myeloid leukemia using the same

US Patent 10000566 · Granted Jun 19, 2018

Estimated economic value: $15,068,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Anti-CD19 antibodies and uses therof2024
Method for increasing the efficacy of cancer therapy by administering an anti-FO2024
Anti-CD123 antibodies and conjugates and derivatives thereof2024
Conjugates comprising cell-binding agents and cytotoxic agents2023
CD37-binding molecules and immunoconjugates thereof2022
Anti-CD123 antibodies and conjugates and derivatives thereof2022
Method for identifying an ovarian cancer in a subject likely to respond to anti-2021
Antibodies and assays for detection of CD372021
Conjugates comprising cell-binding agents and cytotoxic agents2021
Anti-CD123 antibodies and conjugates and derivatives thereof2021
Anti-CD123 antibodies and conjugates and derivatives thereof2020
Folate receptor 1 antibodies and immunoconjugates and uses thereof2020